Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Kiyomi Sasaki is active.

Publication


Featured researches published by Kiyomi Sasaki.


Molecular therapy. Nucleic acids | 2012

Cholesterol-lowering Action of BNA-based Antisense Oligonucleotides Targeting PCSK9 in Atherogenic Diet-induced Hypercholesterolemic Mice

Tsuyoshi Yamamoto; Mariko Harada-Shiba; Moeka Nakatani; Shunsuke Wada; Hidenori Yasuhara; Keisuke Narukawa; Kiyomi Sasaki; Masa-Aki Shibata; Hidetaka Torigoe; Tetsuji Yamaoka; Takeshi Imanishi; Satoshi Obika

Recent findings in molecular biology implicate the involvement of proprotein convertase subtilisin/kexin type 9 (PCSK9) in low-density lipoprotein receptor (LDLR) protein regulation. The cholesterol-lowering potential of anti-PCSK9 antisense oligonucleotides (AONs) modified with bridged nucleic acids (BNA-AONs) including 2′,4′-BNA (also called as locked nucleic acid (LNA)) and 2′,4′-BNANC chemistries were demonstrated both in vitro and in vivo. An in vitro transfection study revealed that all of the BNA-AONs induce dose-dependent reductions in PCSK9 messenger RNA (mRNA) levels concomitantly with increases in LDLR protein levels. BNA-AONs were administered to atherogenic diet-fed C57BL/6J mice twice weekly for 6 weeks; 2′,4′-BNA-AON that targeted murine PCSK9 induced a dose-dependent reduction in hepatic PCSK9 mRNA and LDL cholesterol (LDL-C); the 43% reduction of serum LDL-C was achieved at a dose of 20 mg/kg/injection with only moderate increases in toxicological indicators. In addition, the serum high-density lipoprotein cholesterol (HDL-C) levels increased. These results support antisense inhibition of PCSK9 as a potential therapeutic approach. When compared with 2′,4′-BNA-AON, 2′,4′-BNANC-AON showed an earlier LDL-C–lowering effect and was more tolerable in mice. Our results validate the optimization of 2′,4′-BNANC-based anti-PCSK9 antisense molecules to produce a promising therapeutic agent for the treatment of hypercholesterolemia.


Journal of Biochemistry | 2009

Thermodynamic and Kinetic Effects of Morpholino Modification on Pyrimidine Motif Triplex Nucleic Acid Formation under Physiological Condition

Hidetaka Torigoe; Kiyomi Sasaki; Takuma Katayama

Due to instability of pyrimidine motif triplex nucleic acid under physiological pH and low magnesium ion concentration, stabilization of the triplex under the physiological condition is crucial in improving its therapeutic potential to artificially control gene expression in vivo. To this end, we investigated the thermodynamic and kinetic effects of morpholino (MOR) modification of triplex-forming oligonucleotide (TFO) on the triplex formation under the physiological condition. The thermodynamic analyses indicated that the MOR modification of TFO not only significantly increased the thermal stability of the triplex but also increased the binding constant for the triplex formation by nearly 2 orders of magnitude. The consideration of the observed thermodynamic parameters suggested that the increased rigidity of the MOR-modified TFO in the free state relative to the corresponding unmodified TFO may enable the significant increase in the binding constant. Kinetic data demonstrated that the observed increase in the binding constant resulted from the considerable increase in the association rate constant rather than the decrease in the dissociation rate constant. This information will be valuable for designing novel chemically modified TFO with higher binding affinity in the triplex formation under physiological conditions, leading to progress in therapeutic applications of the antigene strategy in vivo.


Nucleosides, Nucleotides & Nucleic Acids | 2011

Interrupted 2′-O,4′-C-Aminomethylene Bridged Nucleic Acid Modification Enhances Pyrimidine Motif Triplex-Forming Ability and Nuclease Resistance Under Physiological Condition

Hidetaka Torigoe; S. M. Abdur Rahman; Hiroko Takuma; Norihiro Sato; Takeshi Imanishi; Satoshi Obika; Kiyomi Sasaki

Due to instability of pyrimidine motif triplex DNA at physiological pH, triplex stabilization at physiological pH is crucial in improving its potential in various triplex formation-based strategies in vivo, such as regulation of gene expression, mapping of genomic DNA, and gene-targeted mutagenesis. To this end, we investigated the effect of our previously reported chemical modification, 2′-O,4′-C-aminomethylene bridged nucleic acid (2′,4′- BNANC) modification, introduced into interrupted and continuous positions of triplex-forming oligonucleotide (TFO) on pyrimidine motif triplex formation at physiological pH. The interrupted 2′,4′-BNANC modifications of TFO increased the binding constant of the triplex formation at physiological pH by more than 10-fold, and significantly increased the nuclease resistance of TFO. On the other hand, the continuous 2′,4′-BNANC modification of TFO showed lower ability to promote the triplex formation at physiological pH than the interrupted 2′,4′-BNANC modifications of TFO, and did not significantly change the nuclease resistance of TFO. Selection of the interruptedly 2′,4′-BNANC-modified positions in TFO was more favorable for achieving the higher binding affinity of the pyrimidine motif triplex formation at physiological pH and the higher nuclease resistance of TFO than that of the continuously 2′,4′-BNANC-modified positions in TFO. We conclude that the interrupted 2′,4′-BNANC modification of TFO could be a key chemical modification to enhance pyrimidine motif triplex-forming ability and nuclease resistance under physiological condition, and may eventually lead to progress in various triplex formation-based strategies in vivo.


Nucleic acids symposium series (2004) | 2008

DX DNAs as Templates for Multiple Arrangement of Zinc Fingers

Kiyomi Sasaki; Akira Onoda; Mina Mizota; Ryota Sakamoto; Takeshi Yamamura

The present paper reveals that double crossover-DNAs (DX) serve as scaffolds for the multiple arrangement of a [Ru(bpy)(3)](2+)-bound zinc finger (ZF) protein, Ru-ZF. This series of results would lead to the realization of the two-dimensional arrangement of functional molecules and nanomaterials on DX-tiles.


Bulletin of the Chemical Society of Japan | 2009

Circular Dichroism of Neutral Zinc Porphyrin–Oligonucleotide Conjugates Modified with Flexible Linker

Akira Onoda; Masahiro Igarashi; Satoshi Naganawa; Kiyomi Sasaki; Shinya Ariyasu; Takeshi Yamamura


Chemistry: A European Journal | 2011

2'-O,4'-C-Aminomethylene-Bridged Nucleic Acid Modification with Enhancement of Nuclease Resistance Promotes Pyrimidine Motif Triplex Nucleic Acid Formation at Physiological pH

Hidetaka Torigoe; S. M. Abdur Rahman; Hiroko Takuma; Norihiro Sato; Takeshi Imanishi; Satoshi Obika; Kiyomi Sasaki


Biochimie | 2012

Chemical modification of triplex-forming oligonucleotide to promote pyrimidine motif triplex formation at physiological pH.

Hidetaka Torigoe; Osamu Nakagawa; Takeshi Imanishi; Satoshi Obika; Kiyomi Sasaki


Archive | 2011

OLIGONUCLEOTIDE, AND THERAPEUTIC AGENT FOR DYSLIPIDEMIA CONTAINING OLIGONUCLEOTIDE AS ACTIVE INGREDIENT

Satoshi Obika; Takeshi Imanishi; Tsuyoshi Yamamoto; Keisuke Narukawa; Mariko Shiba; Tetsuji Yamaoka; Hidetaka Torigoe; Atsushi Yamashita; Yoichi Tachibana; Sachiro Kakinoki; Kiyomi Sasaki


Nucleic acids symposium series (2004) | 2009

Promotion of triplex formation by 3′-amino-2′-O,4′-C-methylene bridged nucleic acid modification

Kiyomi Sasaki; S. M. Abdur Rahman; Norihiro Sato; Satoshi Obika; Takeshi Imanishi; Hidetaka Torigoe


生物物理 | 2011

3B1446 3本鎖DNAと3本鎖DNA結合蛋白質Stm1の相互作用機構(3B 核酸結合蛋白質,日本生物物理学会第49回年会)

Norihiro Sato; Kiyomi Sasaki; Takuma Katayama; Yusuke Nomura; Hidetaka Torigoe

Collaboration


Dive into the Kiyomi Sasaki's collaboration.

Top Co-Authors

Avatar

Hidetaka Torigoe

Tokyo University of Science

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Norihiro Sato

Tokyo University of Science

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Takuma Katayama

Tokyo University of Science

View shared research outputs
Top Co-Authors

Avatar

Tetsuji Yamaoka

Mitsubishi Chemical Corporation

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge